Status:
UNKNOWN
Misoprostol in the Prevention of Postpartum Haemorrhage
Lead Sponsor:
The University of The West Indies
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
16-45 years
Phase:
PHASE3
Brief Summary
Postpartum haemorrhage is a major contributor to maternal mortality in the developing world. The incidence is between 5 and 12% in Jamaica and varies depending on the route of delivery. Misoprostol is...
Eligibility Criteria
Inclusion
- Pregnant women admitted to the labour wards at University Hospital of the West Indies (UHWI) and Victoria Jubilee Hospital (VJH) undergoing a vaginal delivery
- Consent given to participate in the study
Exclusion
- Women undergoing caesarean section
- Gestational age less than 28 weeks
- Any severe allergic conditions
- Severe asthmatics
- Age \<16 years
- Temperature \>38 degrees Celsius
- Women not wishing to consent to join the study
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
1496 Patients enrolled
Trial Details
Trial ID
NCT04044287
Start Date
January 1 2013
End Date
December 31 2019
Last Update
August 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of the West Indies, Mona
Kingston, Jamaica, Kgn 7